查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1698336

乳房重建市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Breast Reconstruction Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球乳房重建市場規模達到 5.153 億美元，預計 2025 年至 2034 年期間的複合年成長率為 4.9%。推動這一成長的因素包括手術技術的不斷進步、越來越多的女性選擇乳房切除術後重建手術以及人們對可用治療方案的認知不斷提高。由於患者偏好自然的效果和更快的恢復時間，對脂肪移植技術等微創手術的需求持續成長。此外，越來越多優惠的報銷政策和政府支持舉措使得世界各地的患者更容易接受乳房重建手術。

乳房重建市場 - IMG1

3D 列印植入物和生物工程組織支架等尖端技術的整合正在進一步推動市場擴張。人們越來越關注個人化治療方法和加強植入物安全標準，這導致了重大的產品創新。隨著監管框架的發展，製造商在植入物設計中優先考慮生物相容性和耐用性，以確保長期療效和患者滿意度。此外，全球乳癌發生率的上升，加上接受乳房切除術的女性人數的增加，預計將推動未來十年市場的成長軌跡。由於醫療基礎設施的改善和可支配收入的增加，新興市場（尤其是亞太和拉丁美洲）對乳房重建手術的需求正在激增。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 5.153億美元
預測值 8.691億美元
複合年成長率 4.9％

乳房重建市場分為不同的產品領域，包括植入物、組織擴張器、去細胞真皮基質和其他相關產品。植入物佔據最大的市場佔有率，2024 年價值為 3.269 億美元，包括矽膠和鹽水乳房植入物。矽膠植入物因其增強的耐用性、凝聚性凝膠配方和紋理表面設計而廣受歡迎，這些特性有助於提供更自然的感覺和更高的安全性。植入技術的創新預計將繼續影響市場趨勢，各公司將投入大量資金進行研發，以改善植入物的壽命和生物相容性。

乳房重建手術大致分為單側重建和雙側重建。 2024 年，單側乳房重建市場規模達 2.994 億美元，預估 2025 年至 2034 年的複合年成長率為 4.5%。該領域的成長主要得益於乳房切除術後對美觀對稱性的需求不斷成長。尋求單側重建的患者通常注重恢復平衡和獲得自然的外觀，導致手術量穩定上升。先進手術技術和植入材料的出現進一步促進了該領域的持續擴張。

2024 年美國乳房重建市場產值達 2.198 億美元，延續前幾年的上升趨勢。受致力於產品創新和加強安全措施的領先乳房植入物製造商的推動，該領域在 2025 年至 2034 年期間的複合年成長率預計將達到 4.4%。美國市場受益於強大的醫療保健基礎設施、較高的患者意識以及完善的報銷框架，鼓勵更多女性選擇重建手術。該地區的公司正專注於技術進步，例如改進植入物紋理和生物工程解決方案，以滿足患者和醫療保健提供者不斷變化的需求。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 乳癌發生率不斷上升
      • 人們對重建手術的認知不斷提高
      • 植入物和網片的技術進步
      • 美容整形手術激增
    • 產業陷阱與挑戰
      • 乳房重建手術費用高昂
      • 手術風險和併發症
  • 成長潛力分析
  • 監管格局
    • 美國
    • 歐洲
  • 技術格局
  • 報銷場景
  • 波特的分析
  • PESTEL 分析
  • 差距分析
  • 未來市場趨勢
  • 價值鏈分析

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：按產品，2021 - 2034 年

  • 主要趨勢
  • 植入物
    • 矽膠乳房植入物
    • 鹽水乳房植入物
  • 組織擴張器
  • 去細胞真皮基質
  • 其他產品

第6章：市場估計與預測：按類型，2021 - 2034 年

  • 主要趨勢
  • 單側乳房重建
  • 雙側乳房重建

第7章：市場估計與預測：按程序，2021 - 2034 年

  • 主要趨勢
  • 即時
  • 延遲
  • 修訂

第8章：市場估計與預測：依最終用途，2021 - 2034 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用途

第9章：市場估計與預測：按地區，2021 - 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • AbbVie
  • arion LABORATORIES
  • BIMINI HEALTH TECH
  • CEREPLAS
  • Establishment Labs
  • GC Aesthetics
  • HANSBIOMED
  • INTEGRA
  • Johnson & Johnson
  • POLYTECH Health & Aesthetics
  • RTI Surgical
  • Sebbin
  • Sientra
  • SILIMED
  • Wanhe
簡介目錄
Product Code: 13238

The Global Breast Reconstruction Market reached USD 515.3 million in 2024 and is projected to expand at a CAGR of 4.9% between 2025 and 2034. This growth is fueled by continuous advancements in surgical techniques, an increasing number of women opting for reconstructive procedures post-mastectomy, and a rise in awareness about available treatment options. The demand for minimally invasive procedures, such as fat grafting techniques, continues to grow, driven by patient preference for natural-looking results and quicker recovery times. Additionally, an increasing number of favorable reimbursement policies and government support initiatives have made breast reconstruction more accessible to patients worldwide.

Breast Reconstruction Market - IMG1

The integration of cutting-edge technologies, including 3D-printed implants and bioengineered tissue scaffolds, is further driving market expansion. The growing focus on personalized treatment approaches and enhanced implant safety standards has led to significant product innovations. As regulatory frameworks evolve, manufacturers are prioritizing biocompatibility and durability in their implant designs, ensuring long-term efficacy and patient satisfaction. Moreover, the rising prevalence of breast cancer globally, coupled with an increase in the number of women undergoing mastectomy procedures, is expected to fuel the market's upward trajectory over the next decade. Emerging markets, particularly in Asia-Pacific and Latin America, are experiencing a surge in demand for breast reconstruction procedures due to improved healthcare infrastructure and rising disposable incomes.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$515.3 Million
Forecast Value$869.1 Million
CAGR4.9%

The breast reconstruction market is categorized into various product segments, including implants, tissue expanders, acellular dermal matrices, and other related products. Implants hold the largest market share, valued at USD 326.9 million in 2024, and include both silicone and saline breast implants. Silicone implants have gained substantial popularity due to their enhanced durability, cohesive gel formulations, and textured surface designs, which contribute to a more natural feel and improved safety profiles. Innovations in implant technology are expected to continue shaping market trends, with companies investing heavily in research and development to refine implant longevity and biocompatibility.

Breast reconstruction procedures are broadly classified into unilateral and bilateral reconstructions. In 2024, the unilateral breast reconstruction segment accounted for USD 299.4 million and is anticipated to grow at a CAGR of 4.5% from 2025 to 2034. This segment's growth is primarily driven by an increasing demand for aesthetic symmetry following mastectomy. Patients seeking unilateral reconstruction are often focused on restoring balance and achieving a natural appearance, leading to a steady rise in surgical volumes. The availability of advanced surgical techniques and implant materials is further contributing to the segment's sustained expansion.

The U.S. Breast Reconstruction Market generated USD 219.8 million in 2024, continuing its upward trend from previous years. This segment is set to grow at a CAGR of 4.4% between 2025 and 2034, driven by the presence of leading breast implant manufacturers dedicated to product innovation and enhanced safety measures. The U.S. market benefits from a strong healthcare infrastructure, high patient awareness, and a well-established reimbursement framework that encourages more women to opt for reconstructive procedures. Companies in the region are focusing on technological advancements, such as improved implant textures and bioengineered solutions, to meet the evolving needs of both patients and healthcare providers.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of breast cancer
      • 3.2.1.2 Growing awareness about reconstructive surgery
      • 3.2.1.3 Technological advancements in implants and mesh
      • 3.2.1.4 Surge in cosmetic and aesthetic procedures
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of breast reconstruction procedures
      • 3.2.2.2 Surgical risks and complications
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Porter’s analysis
  • 3.8 PESTEL analysis
  • 3.9 Gap analysis
  • 3.10 Future market trends
  • 3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Implants
    • 5.2.1 Silicone breast implants
    • 5.2.2 Saline breast implants
  • 5.3 Tissue expander
  • 5.4 Acellular dermal matrix
  • 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Unilateral breast reconstruction
  • 6.3 Bilateral breast reconstruction

Chapter 7 Market Estimates and Forecast, By Procedure, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Immediate
  • 7.3 Delayed
  • 7.4 Revision

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Other End Use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 AbbVie
  • 10.2 arion LABORATORIES
  • 10.3 BIMINI HEALTH TECH
  • 10.4 CEREPLAS
  • 10.5 Establishment Labs
  • 10.6 GC Aesthetics
  • 10.7 HANSBIOMED
  • 10.8 INTEGRA
  • 10.9 Johnson & Johnson
  • 10.10 POLYTECH Health & Aesthetics
  • 10.11 RTI Surgical
  • 10.12 Sebbin
  • 10.13 Sientra
  • 10.14 SILIMED
  • 10.15 Wanhe